adjuvant ipilimumab in high-risk melanoma
Published 9 years ago • 419 plays • Length 5:57Download video MP4
Download video MP3
Similar videos
-
9:35
adjuvant treatment selection in high-risk melanoma
-
3:31
comment: adjuvant ipilimumab in high-risk melanoma
-
1:24
dr. atkins on adjuvant ipilimumab in melanoma
-
5:28
ipilimumab as adjuvant therapy improves os in high risk melanoma
-
0:53
dr. pavlick on adjuvant immunotherapy in high-risk melanoma
-
3:24
ipilimumab side effect management in melanoma
-
2:22
adjuvant nivolumab in patents with high-risk resected melanoma
-
6:23
adjuvant ipilimumab approval, two breakthrough designations, and more
-
1:30
adjuvant therapy for high-risk melanoma
-
5:00
adjuvant therapy for stage iii melanoma
-
10:18
adjuvant ipilimumab improves recurrence-free survival in high-risk stage iii melanoma
-
6:23
adjuvant therapy options in melanoma treatment
-
6:04
using adjuvant therapy in patients with melanoma
-
5:43
role of adjuvant radiation therapy in melanoma
-
1:18
comment: ipilimumab in high risk stage iii melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
8:52
adjuvant therapy for patients with melanoma
-
9:18
adjuvant immunotherapy for melanoma
-
2:01
dr. sondak on ipilimumab in the adjuvant setting for melanoma